Log in with your NetID to export as a spreadsheet. After you log in, you will need to re-select any search options you've chosen.
Deadline |
Title | Funding Agency | Discipline | Who's Eligible | Award Amount | Date Posted |
|---|---|---|---|---|---|---|
| Deadline: 10/09/2026 | Notice of Special Interest (NOSI): Research Supplements to Promote Re-Entry, Re-integration into, and Re-training in Health-Related Research Careers (Admin Supp - Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 9/11/2023 |
| Deadline: 1/07/2026 | Notice of Special Interest (NOSI): Administrative Supplement for Rapid Translation of Substance Use and Addiction Epidemiology and Prevention Intervention Research | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 12/05/2022 |
| Deadline: 12/03/2024 | Notice of Intent to Publish a Funding Opportunity Announcement for the Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 3/25/2022 |
| Deadline: 12/03/2024 | Notice of Intent to Publish a Funding Opportunity Announcement for Data Management and Coordinating Center (DMCC) for Rare Diseases Clinical Research Network (RDCRN) (U2C Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 3/25/2022 |
| Deadline: 10/01/2024 | Notice of Special Interest (NOSI): Administrative Supplements for Complementary Health Practitioner Research Experience (Admin Supplements) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 3/02/2022 |
| Deadline: 8/15/2024 | Specialized Centers of Research Excellence (SCORE) on Sex Differences (U54 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $7,000,000 | 6/27/2023 |
| Deadline: 6/19/2024 | Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) (R21 Clinical Trials Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $275,000 | 8/09/2023 |
| Deadline: 6/14/2024 | Notice of Intent to Publish a Notice of Funding Opportunity (NOFO) for the Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 5/23/2023 |
| Deadline: 5/17/2024 | Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers (P50 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $7,500,000 | 6/21/2023 |
| Deadline: 2/20/2024 | HEAL Initiative: Translational Development of Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 7/11/2023 |
| Deadline: 2/16/2024 | NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 9/06/2023 |
| Deadline: 2/16/2024 | Notice of Special Interest (NOSI): Developing and Testing Multilevel Physical Activity Interventions to Improve Health and Well-Being | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 |
| Deadline: 2/05/2024 | Notice of Special Interest (NOSI): Advancing Rheumatic Heart Disease Research (R01) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 9/18/2023 |
| Deadline: 1/11/2024 | NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 7/31/2023 |
| Deadline: 12/16/2023 | The role of Epstein Barr virus (EBV) infection in Non-Hodgkin Lymphoma (NHL) and Hodgkin disease (HD) development with or without an underlying HIV infection (U01 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 9/12/2023 |
| Deadline: 12/14/2023 | Notice of Intent to Publish a Funding Opportunity Announcement for Translational Research Toward Development of a Kaposi Sarcoma Herpesvirus (KSHV) Vaccine (U01 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 5/23/2023 |
| Deadline: 12/13/2023 | Pre-application: Opportunities for Collaborative Research at the NIH Clinical Center (X02 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 9/05/2023 |
| Deadline: 12/04/2023 | Partnerships With Common Fund Data Ecosystem Resources (U24 Clinical Trial not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 7/12/2023 |
| Deadline: 11/29/2023 | National Centers for Translational Research in Reproduction and Infertility (NCTRI) (P50 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $4,400,000 | 8/18/2023 |
| Deadline: 11/21/2023 | Catalyze: Product Definition – Device Prototype Testing and Design Modification, Diagnostic Disease Target Assay Development and Design Characterization, and Research Tool Testing and Validation (R33 - Clinical Trials Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: $500,000 | 8/08/2023 |
